Clene Inc (CLNN)
4.96
-1.59%
Clene Inc (CLNN) is currently trading at $4.96. This represents a loss of 1.59% from the previous session. With a market capitalization of $0.05B, CLNN is a key component of the Health Care sector. Investors looking to trade CLNN should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade CLNN commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Clene Inc (CLNN) shows a bearish trend. Analysts are watching the 5.27 level closely.
Fundamentals
Mkt Cap0.05B
P/E Ratio0.0000
Volume59,207
60-Day Technical Chart
Advanced Charting
Need more indicators for CLNN? Use the world's #1 platform.
Open CLNN on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $5
| Metric |
CLNN -1.59% |
OPEN -2.54% |
NIO -2.08% |
SNAP +2.01% |
|---|---|---|---|---|
| Price | $4.96 | $4.98 | $5.19 | $5.07 |
| Mkt Cap | $0.05B | $4.77B | $98.03B | $8.56B |
| - | View → | View → | View → |
Latest Headlines
Experimental ALS drug CNM-Au8 heads toward 2026 FDA review
Stock Titan • Feb 24, 2026
Clene Inc. (CLNN) Reports Q3 Loss, Lags Revenue Estimates
Yahoo Finance • Nov 13, 2025
$CLNN stock is up 14% today. Here's what we see in our data.
Quiver Quantitative • Nov 14, 2025
Biotech Clene raises $28M ahead of potential FDA decision on ALS drug
Stock Titan • Jan 9, 2026
Benchmark reiterates Buy rating on Clene stock amid positive biomarker data
Investing.com • Dec 4, 2025
● Gemini Agentic AI Analyst Insight for CLNN
Market Education
- Tax Loss Selling: A Strategic Way to Offset Gains Dec 10, 2024
- Government Shutdowns: What They Mean for Wall Street Sep 26, 2025
- AI and the Stock Market: How Artificial Intelligence Is Driving a New Bull Run Sep 26, 2025
External Research